Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Unilever mulls sale of historic British food brands - report

(Sharecast News) - Unilever is reportedly considering selling some of its best-known British food brands, including Marmite, as it refocuses on beauty and wellbeing. According to Reuters, citing three unnamed people with knowledge of the matter, the consumer goods giant is considering offloading mustard maker Colman's and Bovril as well as the divisive yeast extract.

It will, however, hold onto Pot Noodle, one of the sources said.

The package of British assets is thought to have revenues of around £200m, Reuters noted.

Unilever declined to comment on the report.

The Anglo-Dutch company owns around 400 brands, including market-leaders such as Dove, Lynx, Persil and Hellman's.

Its products are sold globally, but in line with many in the consumer goods sector, supply chain disruption and high inflation have squeezed margins in recent years.

Chief executive Fernando Fernandez - Unilever's former finance head - has been looking to strengthen sales and profits since taking over the role in February.

He is also pushing ahead with plans to move the group away from food towards beauty and personal care.

So far this year, Unilever has already announced the sale of The Vegetarian Butcher and personal care brand Kate Somerville as well as plans to spin off its ice cream business, home to Magnum and Ben & Jerry's.

Share this article

Related Sharecast Articles

Culture Secretary 'minded to intervene' in Sky-ITV deal
(Sharecast News) - Culture secretary Lisa Nandy on Thursday revealed that she is "minded to intervene" in Sky's proposed takeover of ITV's media and entertainment activities, suggesting possible legislation of the streaming industry may be needed.
AstraZeneca enters into strategic drug discovery deal with AI biotech Insitro
(Sharecast News) - AstraZeneca said on Thursday that it will pay up to $1.86bn to enter a new strategic drug discovery collaboration and licensing agreement with Califiornia-based AI biotech firm Insitro.
Berenberg lifts target price on Discoverie following H1 update
(Sharecast News) - Analysts at Berenberg lifted their target price for DiscoverIE from 1,050p to 1,100p on Thursday, citing sustained organic momentum, a strengthening order book and earnings running ahead of expectations.
Friday preview: Man Group update, eurozone inflation eyed
(Sharecast News) - Friday will mark a fairly quiet end to a busy week that saw the release of a slew of US bank earnings.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.